Pfizer Inc. 13D and 13G filings for Allogene Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-25 5:29 pm Unchanged |
2023-08-02 | 13D | Allogene Therapeutics, Inc. ALLO |
PFIZER INC PFE |
22,032,040 13.140% |
0 (Unchanged) |
Filing |
| 2022-04-07 4:11 pm Unchanged |
2022-03-31 | 13D | Allogene Therapeutics, Inc. ALLO |
PFIZER INC PFE |
22,032,040 15.400% |
0 (Unchanged) |
Filing |
| 2021-09-17 4:17 pm Unchanged |
2021-09-10 | 13D | Allogene Therapeutics, Inc. ALLO |
PFIZER INC PFE |
22,032,040 15.500% |
0 (Unchanged) |
Filing |